SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Immunome Says Varegacestat Reduced Symptoms in Phase 3 Desmoid Tumor Trial

Immunome presented results from a Phase 3 trial of varegacestat in desmoid tumors, reporting reduced symptom burden.

IMNM

Related stories